Vineet Laboratories Ltd Share Price

57.26
(0.25%)
Jul 25, 2024|03:32:22 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open56.26
  • Day's High57.8
  • 52 Wk High88.9
  • Prev. Close57.12
  • Day's Low56.26
  • 52 Wk Low46.6
  • Turnover (lac)4.51
  • P/E51.13
  • Face Value10
  • Book Value37.65
  • EPS1.11
  • Mkt. Cap (Cr.)52.79
  • Div. Yield0
No Records Found

Vineet Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

56.26

Prev. Close

57.12

Turnover(Lac.)

4.51

Day's High

57.8

Day's Low

56.26

52 Week's High

88.9

52 Week's Low

46.6

Book Value

37.65

Face Value

10

Mkt Cap (₹ Cr.)

52.79

P/E

51.13

EPS

1.11

Divi. Yield

0

Vineet Laboratories Ltd Corporate Action

5 Sep 2023

12:00 AM

AGM

Announcement Date: 05 Sep, 2023

arrow

5 Sep 2023

12:00 AM

BookCloser

arrow

21 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Vineet Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vineet Laboratories Ltd SHAREHOLDING SNAPSHOT

25 Jul, 2024|08:31 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 37.50%

Foreign: 0.00%

Indian: 37.50%

Non-Promoter- 62.49%

Institutions: 0.00%

Non-Institutions: 62.49%

Custodian: 0.00%

Share Price

Vineet Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

9.22

9.22

9.22

0.41

Preference Capital

0

0

0

0

Reserves

24.46

24

17.4

-0.01

Net Worth

33.68

33.22

26.62

0.4

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020

Revenue

243.47

0

yoy growth (%)

0

Raw materials

-198.11

0

As % of sales

81.36

0

Employee costs

-5.57

0

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020

Profit before tax

4.05

-0.01

Depreciation

-1.8

0

Tax paid

-2.27

0

Working capital

20.32

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020

Growth matrix (%)

Revenue growth

0

Op profit growth

-73,470.7

EBIT growth

-60,673.29

Net profit growth

-16,135.75

View Ratios

No Record found

Vineet Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,619.45

127.343,88,632.28867.60.835,536.9998.75

Cipla Ltd

CIPLA

1,503.5

32.691,21,442.631,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,551.6

76.631,20,717.855310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,179.45

34.531,18,680.271,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,820.15

26.551,13,730.311,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vineet Laboratories Ltd

Management

Register Office

Registrar Office

Managing Director

Gaddam Venkata Ramana

Whole Time Director & CFO

Bhupathiraju S Raju

Non Executive Director

Kandula Murali Mohan

Independent Director

Dilip V Acharekar

Independent Director

K. Bhaskar Reddy

Company Secretary

Nirosha Ravikanti

Additional Director

Yerukalapudi Hari Priya

Company Sec. & Compli. Officer

Rameshkumar Bandari

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of API Intermediates, Bulk Drugs & fine chemicals.The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size. Special provisions are made to carry out reactions at very low temperature (up to -100C). The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.The Company export the API intermediates, fine chemicals and custom synthesis molecules. The Company is interested in collaborating with exporters who want high quality products for export to other countries. In addition to the list of products enlisted in the website, the Company can manufacture as per customer requirements ,in case having any specific requirement.The Company constructed a warehouse with facilities for sampling both, dispensing booth, packing material room, rejected material room, intermediate room and a day storage for dispensed material 20 calibrated storage tanks from 10 KL to 40 KL available to store various solvents in dedicated tanks. All tanks are equipped with sprinklers and bund walls.The res
Read More

Company FAQs

What is the Vineet Laboratories Ltd share price today?

Down Arrow

The Vineet Laboratories Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹57.26 today.

What is the Market Cap of Vineet Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vineet Laboratories Ltd is ₹52.79 Cr. as of 25 Jul ‘24

What is the PE and PB ratio of Vineet Laboratories Ltd?

Down Arrow

The PE and PB ratios of Vineet Laboratories Ltd is 51.13 and 1.51 as of 25 Jul ‘24

What is the 52 Week High and Low of Vineet Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Vineet Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vineet Laboratories Ltd is ₹46.6 and ₹88.9 as of 25 Jul ‘24

What is the CAGR of Vineet Laboratories Ltd?

Down Arrow

Vineet Laboratories Ltd's CAGR for 5 Years at 4.33%, 3 Years at -20.52%, 1 Year at 11.45%, 6 Month at -19.61%, 3 Month at 6.57% and 1 Month at -6.24%.

What is the shareholding pattern of Vineet Laboratories Ltd?

Down Arrow

The shareholding pattern of Vineet Laboratories Ltd is as follows:
Promoters - 37.50 %
Institutions - 0.00 %
Public - 62.50 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.